Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus at metus arcu. Etiam quis euismod dolor. In hendrerit lacinia nibh et posuere.
Vivamus vitae tellus dui. Sed vel velit nisl. Sed ipsum dui, aliquet volutpat auctor vitae, mattis sed massa. Aenean sed sapien lacinia, suscipit nisl suscipit, congue arcu. Vivamus nec porta risus, et accumsan sapien. Pellentesque eget odio vitae nisi lobortis faucibus. Phasellus sed efficitur elit.
Argo is a command line tool that works from the command prompt, powershell, or terminal windows on Windows, Linux, and MacOS. Argo manages and runs docker images to provide access to customized R environments. The images come with preconfigured R […]
An R package for building pharmacometric data sets. PMDatR distills decades of expert knowledge regarding the intricate needs of pharmacometric analysis datasets. PMDatR builds on top of popular R packages such as dplyr[1] and tidyr[2], so much of the syntax is well known […]
Non-compartmental analysis (NCA) is a subdivision within pharmacokinetics (PK) that calculates PK parameters without deciding on a particular compartmental model and with minimal prior assumptions. qPharmetra has developed the open source R package qpNCA package. It performs all essential PK […]
An R package for exploring and reporting pharmacometric analyses. The toolkit showcases our emphasis on programmatic information processing, for source-to-finish traceability. It reflects decades of accumulated expertise in the efficient transformation of model inputs and outputs. Especially relevant is our experience with PsN, a […]
We use these three core values – creativity , collaboration and consistency – in all our work to serve our clients and ultimately serve the patients with better medicines.
We are over 20 scientists with extensive experience located in the US and Europe. We work closely together and share knowledge to help our clients make better decisions.
Our succes in integrating information into models that generate unique insights, allowing executives to make better drug development decisions, is reflected in our gold-standard research publications.
